Elimination of Mother-To-Child Transmission of HIV Infection: The Drug Resource Enhancement against AIDS and Malnutrition Model

Int J Environ Res Public Health. 2015 Oct 21;12(10):13224-39. doi: 10.3390/ijerph121013224.

Abstract

The Drug Resource Enhancement against AIDS and Malnutrition Program (DREAM) gathered professionals in the field of Elimination of HIV-Mother-To-Child Transmission (EMTCT) in Maputo in 2013 to discuss obstacles and solutions for the elimination of HIV vertical transmission in sub-Saharan Africa. During this workshop, the benefits of administrating combined antiretroviral therapy (cART) to HIV positive women from pregnancy throughout breastfeeding were reviewed. cART is capable of reducing vertical transmission to less than 5% at 24 months of age, as well as maternal mortality and infant mortality in both HIV infected and exposed populations to levels similar to those of uninfected individuals. The challenge for programs targeting eMTCT in developing countries is retention in care and treatment adherence. Both are intrinsically related to the model of care. The drop-out from eMTCT programs before cART initiation ranges from 33%-88% while retention rates at 18-24 months are less than 50%. Comprehensive strategies including peer-to-peer education, social support and laboratory monitoring can reduce refusals to less than 5% and attain retention rates approaching 90%. Several components of the model of care for reduction of HIV-1 MTCT are feasible and implementable in scale-up strategies. A review of this model of care for HIV eMTCT is provided.

Keywords: DREAM program; elimination of HIV MTCT.

Publication types

  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome
  • Africa South of the Sahara
  • Anti-HIV Agents / therapeutic use*
  • Child
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / transmission*
  • HIV-1
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Malnutrition
  • Models, Theoretical*
  • Mothers
  • Pregnancy
  • Pregnancy Complications, Infectious / prevention & control*

Substances

  • Anti-HIV Agents